Home Browse articles Contact ES
About ES Search articles Login
Editorial board Instructions
Print this page Email this page

     Instructions to the Authors

About the Journal |  Scope of the journal|  The Editorial Process |  Copyright of articles published in emerging scientist Authorship Criteria |  Case Reports|   Preparing main manuscript | Detailed instruction on the organization of the manuscript  | Reports based on clinical trials and clinical research | Original Articles | Case Reports | Protection of Patients' Rights..Preparing illustrations and figures  | Preparing tables | Preparing additional files|  Other details|


 About the Journal  Top

Emerging Scientist is an online, print-on-demand, international peer-reviewed journal. The journal is published by Wolters Kluwer Health Medical Research-Medknow. Emerging Scientist publishes articles from diverse fields, offering a unique platform for young scientists and their faculty mentors to publish rigorous and high-quality articles. The journal’s full-text articles are available online at http://www.emergingscientist.com. The journal allows free access (open access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional/subject-based repository. Emerging Scientist operates on “authors pay” model and charges low processing charges of $300 per page. For developing countries, the charges are $150 per page. Partial waivers may be granted at the discretion of the Editor-in-Chief. Please contact the editorial office (editor@emergingscientist.com) for details before you submit your manuscript. Please send a brief abstract of your proposed manuscript, along with your request for partial waivers. The journal does not charge for submission.

 Aims and scope  Top

Emerging Scientist publishes articles from diverse fields, offering a unique platform for students and their faculty mentors to publish rigorous and high-quality articles. Emerging Scientist encourages young researchers from college students to postdoctoral fellows to publish articles based on original research or review articles based on critical review of existing literature. The journal particularly encourages young scientists and beginning faculty to publish novel ideas, hypothesis, or critical evaluation of an existing hypothesis or a theory even if it challenges the status quo. Despite the fact that the main focus of the journal is on biomedical sciences, Emerging Scientist will consider articles from other branches of science such as physics, chemistry, pharmacology, and applied mathematics. Additionally, Emerging Scientist welcomes manuscripts in the area of medical, clinical, and health sciences from health care professionals and researchers. Articles from emerging and interdisciplinary areas related to social sciences and humanities like bioethics, legal implications of medical decisions, and sociology of science will be of great interest to the journal. Primary scope of articles of interest to the journal includes, but is not limited to mechanism of diseases; prevention and diagnosis, therapeutic strategies, epidemiologic al studies, and translational research. For details and other inquiries, please contact Editor-in-Chief (editor@emergingscientist.com).  

 Peer-review and publication processes  Top

Emerging Scientist uses double-blind online peer review to speed up the publication process. The time taken to reach a final decision depends on whether reviewers request revisions, and how quickly authors are able to respond.
Once an article is accepted, it is published in Emerging Scientist immediately as a provisional PDF file. The paper will subsequently be published in both fully browsable web form and as a formatted PDF; the article will then be available through Emerging Scientist and PubMed Central, and will also be included in PubMed.
The ultimate decision regarding the acceptance or rejection of any manuscript lies with the Editor-in-Chief (editor@emergingscientist.com) to whom any appeals against rejection should be addressed.

 The Editorial Process Top

Any manuscript submitted to the journal must not already have been published in another journal or be under consideration by any other journal, although it may have been deposited on a preprint server. Manuscripts must not have already been published in any journal or other citable form, with the exception that the journal is willing to consider peer-reviewing manuscripts that are translations of articles originally published in another language. In this case, the consent of the journal in which the article was originally published must be obtained and the fact that the article has already been published must be made clear on submission and be stated in the abstract. Manuscripts that are derived from papers presented at conferences can be submitted unless they have not been published as part of the conference proceedings in a peer-reviewed journal. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party.

 Copyright of articles published in emerging scientist   Top

Authors who publish in Emerging Scientist retain the right to print and share their work with colleagues for academic purposes only and not sell or authorize anyone else to sell their work. The authors grant rights to SciPubMed, USA and Medknow to distribute the reprints/print versions of their accepted articles at a reasonable cost to anyone who likes to receive them. SciPubMed, USA and Medknow may also make the printed version of the journal available to individual subscribers or libraries. The authors will not be entitled to any royalty from any sales by SciPubMed, USA and Medknow. Submission of a manuscript to Emerging Scientist implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Research carried out on humans must be in compliance with the Helsinki Declaration, and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the “Methods” section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. Informed consent must also be documented. Manuscripts may be rejected if the editorial office considers that the research has not been carried out within an ethical framework, e.g. if the severity of the experimental procedure is not justified by the value of the knowledge gained.
Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the “Methods” section.
We ask authors of Emerging Scientist papers to complete a declaration of competing interests, which should be provided as a separate section of the manuscript, following “Acknowledgments.” Where authors have no competing interests, the listing will read: “The author(s) declare that they have no competing interests.” The following articles provide some background of competing interests:

  • Smith R. Beyond conflict of interest. BMJ 1998; 317:291-2.
  • Smith R. Making progress with competing interests. BMJ 2002; 325:1375-6.
  • DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001; 286:89-9
  • Morin K, Rakatansky H, Riddick FA Jr, Morse LJ, O’Bannon JM 3rd, Goldrich MS, et al. Managing conflicts of interest in the conduct of clinical trials. JAMA 2002; 287:78-84.

For all articles that include information or clinical photographs relating to individual patients, written and signed consent from each patient to publish must also be mailed or faxed to the editorial staff. The manuscript should also include a statement to this effect in the “Acknowledgments” section as follows: “Written consent for publication was obtained from the patient or their relative.”


 Authorship Criteria Top

Authorship credit should be based only on substantial contributions to each of the three components mentioned below:

  1. Concept and design of study or acquisition of data or analysis and interpretation of data;
  2. Drafting the article or revising it critically for important intellectual content; and
  3. inal approval of the version to be published.

Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor toward the study and writing the manuscript. Once submitted, the order cannot be changed without written consent of all the contributors.
Contributors should provide a description of contributions made by each of them toward the manuscript. Description should be divided into the following categories, as applicable: Concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. Authors’ contributions will be printed along with the article. One or more authors should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as “guarantor.”
Manuscripts accepted for publication are copyedited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within 3 days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as “Ahead of Print” immediately on acceptance.
The corresponding author should be a faculty. Graduate students and postdoctoral students can submit manuscripts with the written permission from their mentors, if the mentors are not co-authors. For details and other inquiries, please contact Editor-in-Chief (editor@emergingscientist.com).


 Preparing main manuscript Top

Manuscripts must be submitted online only by one of the authors of the manuscript. Files can be submitted as a batch or one by one. The submission process can be interrupted at any time – when users return to the site, they can carry on from where they left off. During submission, you will be asked to provide a cover letter. Please use this to explain why your manuscript should be published in Emerging Scientist and highlight the potential impact of your manuscript in the field related to your manuscript. 

Style and Language
All manuscripts should follow the general guidelines given below:

  • Uniformly American English should be followed.
  • Write the full term for each abbreviation at its first use in the title, abstract, keywords, and text separately unless it is a standard unit of measure. Numerals from 1 to 10 are spelt out.
  • Numerals at the beginning of the sentence spelt out.
  • Check the manuscript for spelling, grammar, and punctuation errors.
  • If a brand name is cited, supply the manufacturer’s name and address (city and state/country).
  • Species names should be in italics.

All articles submitted to Emerging Scientist should meet COPE criteria described below:

  • Coherent and Sound: The manuscript should follow sound logic. Articles are evaluated for scientific content and presentation of facts and figures. Exaggerated claims and conclusions must be avoided.
  • Original: The idea and content should be original and NOT plagiarized. All articles are rigorously checked for plagiarism and will be returned to authors without further review. Previous work of other scientists published in other sources should be appropriately cited.
  • Professionally written: The language should be professional and NOT offending to anyone even if the points and arguments being made are controversial. Authors are free to express their own views and opinions on any subject, but no derogatory comments are allowed. The editor of Emerging Scientist reserves the right to reject any article for any reason without assigning reasons.
  • English: The manuscript should be written in proper English and should be coherent. All articles are copyedited for spelling, punctuation, and grammar, but the manuscript should be written in proper English to allow the reviewers to be able to understand and assess the suitability of the manuscript for publication. If the authors whose native language is not English like to get help in preparation of their manuscript, the editorial office can refer them to external service providers

Emerging Scientist will not edit submitted manuscripts for style or language before sending the manuscripts for peer review. Reviewers may advise rejection of a manuscript if it is poorly written or has severe grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service. Please contact editor@emergingscientist.com for referrals to affordable copy editing services.


Abbreviations should be used as sparingly as possible. They should be defined when first used.


  • Please use double line spacing.
  • Type the text unjustified, without hyphenating words at line breaks.
  • Use hard returns only to end headings and paragraphs, not to rearrange lines.
  • Capitalize only the first word and proper nouns in the title.
  • All pages should be numbered.
  • Use the Emerging Scientist reference format.
  • Footnotes to text should not be used.
  • Greek and other special characters may be included. If you are unable to reproduce a particular special character, please type out the name of the symbol in full.
  • Gene names should be in italic, but protein products should be in plain type.

Please ensure that all special characters used are embedded in the text, otherwise they will be lost during conversion to PDF.


SI units should be used throughout (liter and molar are permitted, however).

Please note

  • Follow the standard format for original articles (Abstract, IMRAD: Introduction, Material and Methods, Results, Discussion) with no other subheadings.
  • Do not divide Material and Methods, Results, and Discussion into various subheadings.
  • For review articles, include the method of literature search, along with the keywords used, in “Abstract” as well as in the “Introduction” section.
  • Results should be more than mere enumeration of tables.

Assistance with the process of manuscript preparation and submission is available from the customer support team (editor@emergingscientist.com).
The submitting author takes responsibility for the article during submission and peer review. The submitting author accepts responsibility for getting the approval from all the authors and keeping them informed of the editorial decisions. The corresponding author will take full responsibility for the accuracy, originality, and scientific integrity of the research presented in the manuscript.


File Formats
Examples of acceptable commonly used file formats are given below:

  • Microsoft Word (Version 2 and above)
  • Rich text format (RTF)
  • Excel files for tables
  • WMV MEG files for videos
  • PDF files for images

Maximum file size allowed for articles:

  • First-page file (including cover letter): 1 MB
  • Article file: 1 MB

Additional files of any type, such as movies, animations, or original data files, can also be submitted as part of the publication.


Article Types
When submitting your manuscript, you will be asked to assign one of the following types to your article:

  • Original research
  • Commentary/Opinion
  • Mini reviews and full reviews
  • Short communications

Please read the descriptions of each of the article types, choose which is appropriate for your article, and structure it accordingly. If in doubt, your manuscript should be classified as Research, the structure for which is described below.


Organization of the Manuscript
Manuscripts for Research articles submitted to Emerging Scientist should be divided into the following sections:

  • Title page
  • Abstract
  • Keywords
  • Background
  • Methods
  • Results
  • Discussion
  • Conclusions
  • List of abbreviations used (if any)
  • Competing interests
  • Authors’ contributions
  • Acknowledgments
  • References
  • Figure legends (if any)
  • Tables and captions (if any)
  • Description of additional data files (if any)
 Detailed instruction on the organization of the manuscript Top

There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is no restriction on the number of figures, tables, or additional files that can be included with each article online. However, please remember page charges apply for all pages. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article.

Title Page
This should list the title of the article.
The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page. The corresponding author should also be indicated.

Article File
Any information which shall reveal the identity of author should be excluded from the article text file. Author information should be included only in the first-page file.

The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background, the context, and purpose of the study; Methods, how the study was performed and statistical tests used; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations, and do not cite references in the abstract. Trial registration – if your research article reports the results of a controlled healthcare intervention, please list your trial registry, along with the unique identifying number, e.g. Trial registration: Current Controlled Trials ISRCTN73824458. Please note that there should be no space between the letters and numbers of your trial registration number.

There must be at least three keywords identified in the manuscript.

The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state – and, if helpful, illustrate – the background to the research and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field. The section should end with a very brief statement of what is being reported in the article.

This should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation, if appropriate.

Results and Discussion
The Results and Discussion may be combined into a single section or presented separately. Results of statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals. The results and discussion sections may also be broken into subsections with short, informative headings.

This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.

List of abbreviations
If abbreviations are used in the text, they should be defined in the text where first used.

Competing interests
A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose not only any financial competing interests, but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript. Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read: “The author(s) declare that they have no competing interests.” When completing your declaration, please consider the following questions:

Financial competing interests

  • In the past 5 years, have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.
  • Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.
  • Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.
  • Do you have any other financial competing interests? If so, please specify.


Non-financial competing interests
Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial, or any other) to declare in relation to this manuscript? If so, please specify.
If you are unsure as to whether you, or one your co-authors, has a competing interest, please discuss it with the editorial office.

Authors’ contributions
In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.
An “author” is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author, one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
We suggest the following kind of format (please use initials to refer to each author’s contribution): AB carried out the molecular genetic studies, participated in the sequence alignment, and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.

Please acknowledge anyone who contributed toward the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.
The role of a medical writer must be included in the “Acknowledgments” section, including their source(s) of funding.
Authors should obtain permission to acknowledge from all those mentioned in the “Acknowledgments.”
Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the “Acknowledgments” section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

References All references must be numbered consecutively, in square brackets and in superscript format, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized, and the bibliography must be fully formatted before submission.
Only articles and abstracts that have been published or are in press or are available through public e-print/preprint servers may be cited; unpublished abstracts, unpublished data, and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE.
The references cited in the text should be after punctuation marks, in superscript format with square brackets.
List the first six contributors followed by et al, do not include unnecessary bibliographic elements such as month, issue, bracket. Follow the punctuation marks carefully and provide the correct abbreviations for journal titles; follow the correct order of citing bibliographic elements; do not use italics for the journal title; for references from books, all the bibliographic elements should be included. Please refer to the recently published article for ready reference.

Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL, in the following format: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

How to Cite References?
Examples on how to cite different types of references are given below.
1. Article within a journal
Koonin EV, Altschul SF, Bork P. BRCA1 protein products: functional motifs. Nat Genet 1996; 13:266-7.
2. Article within a journal supplement
Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I. Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999; 43 (Suppl 3):149-70.
3. In press article
Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J in press.
4. Published abstract
Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN. Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum 1999; 42:s250.
5. Article within conference proceedings
Jones X. Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996. In: Stoneham SY, editor. Baltimore: Butterworth-Heinemann; 1996. p. 16-27.

6. Book chapter or article within a book
Schnepf E. From prey via endosymbiont to plastids: Comparative studies in dinoflagellates. In Origins of Plastids. Vol 2. 2nd ed. In: Lewin RA, editor. New York: Chapman and Hall; 1993. p. 53-76.
7. Whole issue of journal
Ponder B, Johnston S, Chodosh L (Eds). Innovative oncology. In Breast Cancer Res 1998; 10:1-72.
8. Whole conference proceedings
Smith Y (Ed). Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996.
9. Complete book
Margulis L. Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970.
10. Monograph or book in a series
Hunninghake GW, Gadek JE. The alveolar macrophage. In Cultured Human Cells and Tissues. In: Harris TJ, editor. New York: Academic Press; 1995. p. 54-6. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, Vol. 1.]
11. Book with institutional author
Advisory Committee on Genetic Modification: Annual Report. London: 1999.
12. PhD thesis
Kohavi R. Wrappers for performance enhancement and oblivious decision graphs. PhD thesis. Stanford University, Computer Science Department; 1995.
13. Link / URL
The Mouse Tumor Biology Database Available from: http://tumor.informatics.jax.org/cancer_links.html.

 Reports based on clinical trials and clinical research Top

Emerging Scientist supports initiatives to improve the performance and reporting of clinical trials, part of which includes prospective registering and numbering of trials. While there are initiatives to ensure that all clinical trials are registered (most notably the recent statement from the International Committee of Medical Journal Editors – see http://www.icmje.org/clin_trialup.htm), we are focusing on controlled trials of healthcare interventions for now. Authors of protocols or reports of controlled trials of healthcare interventions must register their trial prior to submission in a suitable publicly accessible registry. The trial registers that currently meet all of the ICMJE guidelines can be found at http://www.icmje.org/faq.pdf.
The trial registration number should be included as the last line of the abstract of the manuscript.

 Original Articles Top

These include randomized controlled trials, intervention studies, studies of screening and diagnostic test, outcome studies, cost effectiveness analyses, case–control series, and surveys with high response rate. The text of original articles amounting to up to 3000 words (excluding Abstract, References, and Tables) should be divided into sections with the headings: Abstract, Key-words, Introduction, Materials and Methods, Results, Discussion, References, Tables, and Figure legends.

State the purpose and summarize the rationale for the study or observation.

Materials and Methods
It should include and describe the following aspects:

When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). For prospective studies involving human participants, authors are expected to mention about approval of regional/national/institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants, and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide, or any national law on the care and use of laboratory animals was followed.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible, and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively. The journal will not consider any paper, which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the “Materials and Methods” section.

Study design
Selection and description of participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well-known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).

Whenever possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as dropouts from a clinical trial). When data are summarized in the “Results” section, specify the statistical methods used to analyze them. Avoid non-technical usage of technical terms in statistics, such as “random” (which implies a randomizing device), “normal,” “significant,” “correlations,” and “sample.” Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values, include the exact value and not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables, and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.

Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra or supplementary materials and technical detail can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.
When data are summarized in the “Results” section, give numeric results not only as derivatives (e.g. percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analysis of the data by variables such as age and sex should be included.

Include summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); strengths and limitations of the study (study question, study design, data collection, analysis, and interpretation); interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now? what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); controversies raised by this study; and future research directions (for this particular research collaboration, underlying mechanisms, clinical research).
Do not repeat in detail data or other material given in the “Introduction” or the “Results” section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. New hypotheses may be stated if needed; however, they should be clearly labeled as such. About 30 references can be included. These articles generally should not have more than six authors unless it is compelling to include authors who meet the criteria of authorship.

 Case Reports Top

New, interesting, and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1000 words (excluding abstract and references) and should have the following headings: Abstract (unstructured), Key-words, Introduction, Case reports, Discussion, Reference, Tables, and Legends in that order.
The manuscript could be of up to 1000 words (excluding references and abstract) and could be supported with up to 10 references. Case reports could be authored by up to four authors.

Protection of Patients' Rights to Privacy  Top

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives written informed consent for publication. Authors should remove patients’ names from figures unless they have obtained written informed consent from the patients. When informed consent has been obtained, it should be indicated in the article, and copy of the consent should be attached with the covering letter.
Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should adhere to the Good Publication Practice guidelines for pharmaceutical companies, which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any company or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations, and communications’ companies.
The involvement of medical writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged, along with their source of funding, as described in the European Medical Writers’ Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. If medical writers are not listed among the authors, it is important that their role be acknowledged explicitly. We suggest wording such as “We thank Jane Doe who provided medical writing services on behalf of XYZ Pharmaceuticals Ltd.”
Any “in press” articles cited within the references and necessary for the reviewers’ assessment of the manuscript should be made available if requested by the editorial office.
Submission of a manuscript to Emerging Scientist implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.

Preparing illustrations and figures Top

Figures should be provided as separate files and should not be included in the main text of the submitted manuscript. Each figure should comprise only a single file. There is no charge for the use of color.

The following file formats can be accepted:

    PNG (preferred format for photos or images)
  • GIF

Maximum size allowed per image: 4 MB


Figure Legends
The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals – i.e. Figure 1, 2, 3, etc.); short title of figure (maximum 15 words); detailed legend, up to 300 words.
Patient’s or institute’s identity should not be revealed in the clinical photographs.


Preparing tables Top


  1. Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3, etc.). Tables should also have a title that summarizes the whole table, with maximum 15 words. Detailed legends may then follow, but should be concise.
  2. Smaller tables considered to be integral to the manuscript can be pasted at the end of the document text file in portrait format (note that tables on a landscape page must be reformatted onto a portrait page or be submitted as additional files). These will be typeset and displayed in the final published form of the article. Such tables should be formatted using the “Table object” in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text. Commas should not be used to indicate numerical values. Color and shading should not be used.
  3. Larger datasets can be uploaded separately as additional files. Additional files will not be displayed in the final, published form of the article, but a link will be provided to the files as supplied by the author.
  4. Tables should be self-sufficient: provide a complete title and all the abbreviations should be spelt in the footer of table. Explanations should be in the footnote of the tables. For footnotes in the table, use the following symbols in this sequence: *, †, ‡, §, ¦, ¶, **, ††, ‡‡
  5. Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls). As with all files, please use the standard file extensions.
  6. Tables should only be provided at the end of the text. Quote the table numbers at the relevant place in the text.
Preparing additional files Top

Although Emerging Scientist does not restrict the length and quantity of data in a paper, there may still be occasions where an author wishes to provide data sets, tables, movie files, or other information as additional information. These files can be uploaded using the “Additional Material files” button in the manuscript submission process.
The maximum file size for additional files is 20 MB each, and files will be virus-scanned on submission.
Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided.
If additional material is provided, please list the following information in a separate section of the manuscript text, immediately following the tables (if any):

  • File name
  • File format (including name and a URL of an appropriate viewer if the format is unusual)
  • Title of data
  • Description of data

Additional data files should be referenced explicitly by file name within the body of the article, e.g. “See additional file 1: Movie1 for the original data used to perform this analysis.”


Formats and Uploading
Ideally, file formats for additional files should not be platform-specific, and should be viewable using free or widely available tools. The following are examples of suitable formats:

  • Additional documentation
    PDF (Adobe Acrobat)
  • Movies
    MOV (QuickTime)
    MPG (MPEG)
  • Tabular data
    XLS (Excel spreadsheet)

As with figure files, files should be given the standard file extensions. This is especially important for Macintosh users, since the Mac OS does not enforce the use of standard extensions. Please also make sure that each additional file is a single table, figure, or movie (please do not upload linked worksheets or PDF files larger than one sheet).


Other details Top

The Accession Numbers of any nucleic acid sequences, protein sequences, or atomic coordinates cited in the manuscript should be provided in square brackets and include the corresponding database name; e.g. [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].
The databases for which we can provide direct links are: EMBL Nucleotide Sequence Database (EMBL), DNA Data Bank of Japan (DDBJ), GenBank at the NCBI (GenBank), Protein Data Bank (PDB), Protein Information Resource (PIR), and the Swiss-Prot Protein Database (Swiss-Prot).

Nucleotide Sequences
Nucleotide sequences can be deposited with the DNA Data Bank of Japan (DDBJ), European Molecular Biology Laboratory (EMBL/EBI) Nucleotide Sequence Database, or GenBank (National Center for Biotechnology Information).

Protein sequences
Protein sequences can be deposited with Swiss-Prot or the Protein Information Resource (PIR).

Protein structures can be deposited with one of the members of the Worldwide Protein Data Bank. Nucleic Acids’ structures can be deposited with the Nucleic Acid Database at Rutgers. Crystal structures of organic compounds can be deposited with the Cambridge Crystallographic Data Center.

Chemical Structures and Assays
Structures of chemical substances can be deposited with PubChem Substance. Bioactivity screens of chemical substances can be deposited with PubChem BioAssay.

Microarray Data
Where appropriate, authors should adhere to the standards proposed by the Microarray Gene Expression Data Society and must deposit microarray data in one of the public repositories, such as ArrayExpress, Gene Expression Omnibus (GEO), or the Center for Information Biology Gene Expression Database (CIBEX).

Computational Modeling
We encourage authors to prepare models of biochemical reaction networks using the Systems Biology Markup Language and to deposit the model with the BioModels database, as well as submitting it as an additional file with the manuscript.

We encourage authors to deposit copies of their plasmids as DNA or bacterial stocks with Addgene, a non-profit repository, or PlasmID, the Plasmid Information Database at Harvard.

Templates and Sample of Published Articles
Templates and sample of published articles are available on the journal’s website http://www.emergingscientist.com/contributors.asp

Click here to download instructions

Click here to download copyright form


These ready to use templates are made to help the contributors write as per the requirements of the Journal.

Save the templates on your computer and use them with a word processor program. 
Click open the file and save as the manuscript file.

In the program keep 'Document Map' and 'Comments' on from 'View' menu to navigate through the file. 

Download Template for Original Articles/ABSTRACT Reports. (.DOT file)

Download Template for Case Reports.  (.DOT file)

Download Template for Review Articles.  (.DOT file)

Download Template for Letter to the Editor.  (.DOT file)


What's New
Reference style (PPS)
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal